ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Plasma Epstein-Barr Virus DNA Load After Induction Chemotherapy Predicts Outcome in Locoregionally Advanced Nasopharyngeal Carcinoma

Cheng-Long Huang; Zheng-Qiang Sun; Rui Guo; Xu Liu; Yan-Ping Mao; Hao Peng; Li Tian; Ai-Hua Lin; Li Li; Jian-Yong Shao; Ying Sun; Jun Ma; Ling-Long Tang
International Journal of Radiation Oncology Biology Physics2019-6-1DOI: 10.1016/j.ijrobp.2019.01.007
8阅读
引用收藏
分享

摘要

Purpose<br/>To investigate whether plasma Epstein-Barr virus (EBV) DNA load at induction chemotherapy (ICT) completion (postICT-DNA) is a useful outcome predictor in locoregionally advanced nasopharyngeal carcinoma (NPC) and to compare the prognostic value of postICT- DNA and post–chemoradiation therapy (CCRT) DNA (postRT-DNA).<br/>Methods and Materials<br/>We retrospectively reviewed 278 patients with stage III-IV NPC treated with ICT followed by concurrent CCRT. The EBV DNA load was measured by quantitative polymerase chain reaction pre-ICT (pre-DNA), at ICT completion (postICT-DNA), and 1?week after CCRT completion (postRT-DNA).<br/>Results<br/>PostICT-DNA was associated with significantly worse 3-year overall survival (86.4% vs. 93.4%, P?=?.023), distant metastasis–free survival (69.2% vs. 93.9%, P?<?.001), and disease-free survival (64.6% vs. 88.7%, P?<?.001) than was undetectable postICT-DNA. In multivariate analysis, postICT-DNA was an independent predictor of overall survival (hazard ratio [HR], 2.567; 95% confidence interval [CI], 1.104-5.967; P?=?.029), distant metastasis–free survival (HR, 5.618; 95% CI, 2.781-11.348; P?<?.001), and disease-free survival (HR, 3.672; 95% CI, 2.064-6.533; P?<?.001). The postICT-DNA and postRT-DNA areas under the curve were 0.584 and 0.561 (P?<?.001), respectively, for predicting 3-year death; 0.717 and 0.649 (P?<?.001), respectively, for predicting 3-year metastasis; and 0.659 and 0.602 (P?<?.001), respectively, for predicting 3-year disease failure.<br/>Conclusions<br/>Plasma EBV DNA load at ICT completion is a powerful and earlier outcome predictor in locoregionally advanced NPC that would facilitate further risk stratification and early treatment modification.

相关
加载中…
  • Circulating Epstein-Barr virus DNA level post induction chemotherapy contributes to prognostication in advanced-stage nasopharyngeal carcinoma
    Chen, Fo-Ping; Luo, Ying-Shan; Chen, Kai; Li, Jun-Yun; Huo, Lan-Qing; Shi, Liu; Ou-Yang, Yi; Cao, Xin-Ping*European Journal of Cancer, 2021, 151: 63-71.
  • The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma
    Liu, Li Ting; Tang, Lin Quan; Chen, Qiu Yan; Zhang, Lu; Guo, Shan Shan; Guo, Ling; Mo, Hao Yuan; Zhao, Chong; Guo, Xiang; Cao, Ka Jia; Qian, Chao Nan; Zeng, Mu Sheng; Bei, Jin Xin; Hong, Ming Huang; Shao, Jian Yong; Sun, Ying; Ma, Jun; Mai, Hai Qiang*International Journal of Radiation Oncology Biology Physics, 2015, 93(4): 862-869.被引 93
  • Long-term monitoring of dynamic changes in plasma EBV DNA for improved prognosis prediction of nasopharyngeal carcinoma
    Li, Wanxia; Chen, Jing; Liang, Bijun; Li, Zonghua; Li, Junzheng; Yuan, Xiaofei; Wu, Shuting; Zeng, Fangfang; Peng, Xinyu; Li, Yanfei; Lu, Juan*; Zhao, Feipeng*; Liu, Xiong*Cancer Medicine, 2021, 10(3): 883-894.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of Radiation Oncology Biology Physics
发表日期
2019-06-01
卷期
第 104 卷, 第 2 期
页码
355-361
DOI
10.1016/j.ijrobp.2019.01.007
语言
ENGLISH
成果收录
SCIENCEDIRECT

作者

  • C

    Cheng-Long Huang (第一作者)

  • Z

    Zheng-Qiang Sun

查看全部 13 位作者收起作者
  • R

    Rui Guo

  • X

    Xu Liu

  • Y

    Yan-Ping Mao

  • H

    Hao Peng

  • L

    Li Tian

  • A

    Ai-Hua Lin

  • L

    Li Li

  • J

    Jian-Yong Shao

  • Y

    Ying Sun

  • J

    Jun Ma

  • L

    Ling-Long Tang

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417